FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4305070944> ?p ?o ?g. }

• W4305070944 endingPage "120" @default.
• W4305070944 startingPage "116" @default.
• W4305070944 abstract "Patients with multiple traumas are at high risk of developing respiratory complications, including pneumonia and acute respiratory distress syndrome. Many pulmonary complications are associated with systemic inflammation and pulmonary neutrophilic infiltration. Leukotriene-receptor antagonists are anti-inflammatory and anti-oxidant drugs subsiding airway inflammation. The present study investigates the effectiveness of montelukast in reducing pulmonary complications among trauma patients.This randomized, double-blind, placebo-control trial was conducted in patients with multiple blunt traumas and evidence of lung contusion detected via CT scan. We excluded patients if they met at least one of the following conditions: < 16 years old, history of cardiopulmonary diseases or positive history of montelukast-induced hypersensitivity reactions. Patients were allocated to the treatment (10 mg of montelukast) or placebo group using permuted block randomization method. The primary measured outcome was the volume of pulmonary contusion at the end of the trial. The secondary outcomes were intensive care unit and hospital length of stay, ventilation days, multi-organ failure, and the in-hospital mortality rate.In total, 65 eligible patients (treatment = 31, placebo = 34) were included for the final analysis. The treatment group had more pulmonary contusion volume (mean (SD), mm3) at the right (68726.97 (93656.54) vs. 59730.27 (76551.74)) and the left side (67501.71 (91514.04) vs. 46502.21 (80604.21)), higher initial C-reactive peptide level (12.16 (10.58) vs. 10.85 (17.87)) compared to the placebo group, but the differences were not statistically significant (p > 0.05). At the end of the study, the mean (SD) of pulmonary contusion volume (mm3) (right side = 116748.74 (361705.12), left side = 64522.03 (117266.17)) of the treatment group were comparable to that of the placebo group (right side = 40051.26 (64081.56), left side = 25929.12 (47417.13), p = 0.228 and 0.082, respectively). Moreover, both groups have statistically similar hospital (mean (SD), days) (10.87 (9.83) vs. 13.05 (10.12)) and intensive care unit length of stays (mean (SD), days) (7.16 (8.15) vs. 7.82 (7.48)). Of note, the frequency of the in-hospital complications (treatment vs. control group) including acute respiratory distress syndrome (12.9% vs. 8.8%, p = 0.71), pneumonia (19.4% vs. 17.6%, p = 0.85), multi-organ failure (12.9% vs. 17.6%, p = 0.58) and the mortality rate (22.6% vs. 14.7%, p = 0.41) were comparable between the groups.Administrating montelukast has no preventive or therapeutic effects on lung contusion or its complications." @default.
• W4305070944 created "2022-10-14" @default.
• W4305070944 creator A5013802272 @default.
• W4305070944 creator A5017900797 @default.
• W4305070944 creator A5045106287 @default.
• W4305070944 creator A5046625815 @default.
• W4305070944 creator A5057924410 @default.
• W4305070944 date "2023-03-01" @default.
• W4305070944 modified "2023-09-30" @default.
• W4305070944 title "Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: A double-blind, randomized clinical trial" @default.
• W4305070944 cites W1985892094 @default.
• W4305070944 cites W1988295459 @default.
• W4305070944 cites W2013292745 @default.
• W4305070944 cites W2080389513 @default.
• W4305070944 cites W2111593190 @default.
• W4305070944 cites W2131825199 @default.
• W4305070944 cites W2162732275 @default.
• W4305070944 cites W2507370326 @default.
• W4305070944 cites W2681483049 @default.
• W4305070944 cites W2760457367 @default.
• W4305070944 cites W2921009232 @default.
• W4305070944 cites W2938039838 @default.
• W4305070944 cites W3104486093 @default.
• W4305070944 cites W3150105278 @default.
• W4305070944 cites W3162189894 @default.
• W4305070944 cites W3212427018 @default.
• W4305070944 cites W4282570047 @default.
• W4305070944 doi "https://doi.org/10.1016/j.cjtee.2022.10.002" @default.
• W4305070944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36357273" @default.
• W4305070944 hasPublicationYear "2023" @default.
• W4305070944 type Work @default.
• W4305070944 citedByCount "1" @default.
• W4305070944 countsByYear W43050709442023 @default.
• W4305070944 crossrefType "journal-article" @default.
• W4305070944 hasAuthorship W4305070944A5013802272 @default.
• W4305070944 hasAuthorship W4305070944A5017900797 @default.
• W4305070944 hasAuthorship W4305070944A5045106287 @default.
• W4305070944 hasAuthorship W4305070944A5046625815 @default.
• W4305070944 hasAuthorship W4305070944A5057924410 @default.
• W4305070944 hasBestOaLocation W43050709441 @default.
• W4305070944 hasConcept C126322002 @default.
• W4305070944 hasConcept C141071460 @default.
• W4305070944 hasConcept C141983124 @default.
• W4305070944 hasConcept C142724271 @default.
• W4305070944 hasConcept C168563851 @default.
• W4305070944 hasConcept C204787440 @default.
• W4305070944 hasConcept C27081682 @default.
• W4305070944 hasConcept C2776042228 @default.
• W4305070944 hasConcept C2776322731 @default.
• W4305070944 hasConcept C2777080012 @default.
• W4305070944 hasConcept C2777714996 @default.
• W4305070944 hasConcept C2777914695 @default.
• W4305070944 hasConcept C2780229392 @default.
• W4305070944 hasConcept C42219234 @default.
• W4305070944 hasConcept C71924100 @default.
• W4305070944 hasConceptScore W4305070944C126322002 @default.
• W4305070944 hasConceptScore W4305070944C141071460 @default.
• W4305070944 hasConceptScore W4305070944C141983124 @default.
• W4305070944 hasConceptScore W4305070944C142724271 @default.
• W4305070944 hasConceptScore W4305070944C168563851 @default.
• W4305070944 hasConceptScore W4305070944C204787440 @default.
• W4305070944 hasConceptScore W4305070944C27081682 @default.
• W4305070944 hasConceptScore W4305070944C2776042228 @default.
• W4305070944 hasConceptScore W4305070944C2776322731 @default.
• W4305070944 hasConceptScore W4305070944C2777080012 @default.
• W4305070944 hasConceptScore W4305070944C2777714996 @default.
• W4305070944 hasConceptScore W4305070944C2777914695 @default.
• W4305070944 hasConceptScore W4305070944C2780229392 @default.
• W4305070944 hasConceptScore W4305070944C42219234 @default.
• W4305070944 hasConceptScore W4305070944C71924100 @default.
• W4305070944 hasIssue "2" @default.
• W4305070944 hasLocation W43050709441 @default.
• W4305070944 hasLocation W43050709442 @default.
• W4305070944 hasLocation W43050709443 @default.
• W4305070944 hasOpenAccess W4305070944 @default.
• W4305070944 hasPrimaryLocation W43050709441 @default.
• W4305070944 hasRelatedWork W1998759167 @default.
• W4305070944 hasRelatedWork W2000526237 @default.
• W4305070944 hasRelatedWork W2018270163 @default.
• W4305070944 hasRelatedWork W2033836503 @default.
• W4305070944 hasRelatedWork W2034887372 @default.
• W4305070944 hasRelatedWork W2069946977 @default.
• W4305070944 hasRelatedWork W2163521166 @default.
• W4305070944 hasRelatedWork W2360016312 @default.
• W4305070944 hasRelatedWork W2619141725 @default.
• W4305070944 hasRelatedWork W3120464161 @default.
• W4305070944 hasVolume "26" @default.
• W4305070944 isParatext "false" @default.
• W4305070944 isRetracted "false" @default.
• W4305070944 workType "article" @default.